Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology
Disease area: Respiratory infections, Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Z. Mansour, X. Ducrocq, M. Vasilesu, J. M. Wihlm, E. Quoix, G. Massard (Strasbourg, France). Can we still justify pneumonectomy following induction chemotherapy?. Eur Respir J 2006; 28: Suppl. 50, 4388

Member's Comments

No comment yet.

Related content which might interest you: Does induction chemotherapy increase operative risk of pneumonectomy? Source: ISSN=ISSN 1810-6838, ISBN=, page=66 Year: 2007 The surgical treatment of lung cancer Source: Eur Respir Mon; 2009: 44: 187–206 Year: 2009 Persistent N2-disease after induction therapy does not jeopardize outcomes of pneumonectomy Source: Annual Congress 2007 - Prognostic factors in lung cancer surgery Year: 2007 Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour Source: Eur Respir J 2007; 29: 117-126 Year: 2007 Surgery and multimodality treatment for malignant pleural mesothelioma Source: Eur Respir Mon; 2009: 44: 407–418 Year: 2009 Bronchopleural fistula-risk factors and treatment after lung cancer surgery Source: Annual Congress 2007 - Prognostic factors in lung cancer surgery Year: 2007 ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy) Source: Eur Respir J 2009; 34: 17-41 Year: 2009 Impact of neoadjuvant therapies on surgical indications and early postoperative outcome Source: Annual Congress 2005 - Multidisciplinary treatment of non-metastatic non-small cell lung cancer: contemporary concepts Year: 2005 Respective indications of chemotherapy, radiotherapy and surgery in limited disease stage small cell lung carcinoma Source: Annual Congress 2005 - Neuroendocrine tumours of the lung Year: 2005 Pre-operative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage nonsmall cell lung cancer Source: Breathe 2010; 7: 196-197 Year: 2010 Balanced indications for surgery or endobronchial therapy for typical carcinoid tumours Source: Annual Congress 2005 - Neuroendocrine tumours of the lung Year: 2005 Surgery following neoadjuvant therapy is safe and offers improved long-term prognosis Source: Annual Congress 2007 - Controversies in surgical oncology Year: 2007 Locally advanced disease – indications and results of extended resections Source: Annual Congress 2005 - Borderline indications for surgical treatment of non-small cell lung cancer Year: 2005 Long-term follow-up comparing postoperative chemotherapy or radiotherapy and surgery with surgery alone in resectable nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2001; 18: Suppl. 33, 131s Year: 2001 Neoadjuvant chemotherapy for NSCLC, lung function and surgical therapy – which is their connection? Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications Year: 2019 Surgical and survival outcomes of sleeve lobectomy after neoadjuvant theraphy in lung cancer: With group of 265 patients Source: Virtual Congress 2021 – COVID-19 and management of lung cancer Year: 2021 The effect of neoadjuvant chemoradiotherapy on airway colonization and post operative respiratory complications in the patients undergoing esophagectomy for esophageal cancer Source: Annual Congress 2011 - General thoracic surgery II Year: 2011 SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection Source: Eur Respir J, 56 (5) 2000118; 10.1183/13993003.00118-2020 Year: 2020